Loading...

OSTX OS THERAPIES INC Company Mergers 8-K Filing

S TH

STX

OS THERAPIES INC

(OSTX)

2025 8-K

Stock Resale Filing

Private Placement Agreement

Warrant Exercise Extension

Warrant Inducement Offer

Management Changes

Annual Meeting Update

Prospectus Filed

Warrant Exchange Offer

Termination Notice

Financial Results Update

Bylaw Amendment

Rights Offerings

Equity Offerings

Equity Offerings

Financial Statements

Asset Acquisition

Share Issuance Vote

Special Meeting Adjournment

Financial Results

Asset Acquisition

Private Placement Completion

Private Placement Update

Private Placement Completed

Capital Raise Agreement

Q3 Financial Results

Equity Purchase Agreement

Management Changes

Stock Trading Info

Partnership Announcement

External Links:

On April 9, 2025, OS Therapies completed the acquisition of HER2 Assets from Ayala Pharmaceuticals for $8 million, which includes two drug candidates for cancer treatment and significant reductions in milestone payments and royalties owed to Ayala.

AI Assistant

OS THERAPIES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.